Skip to content
Basket0
Basket

Your basket is empty.

Your basket is empty.

View basket
☰

Zopiclone

Zopiclone
In stock
10mg
from 34,40 £
Strength
Pack size — the bigger the pack, the cheaper the tablet
41,28 £34,40 £
0,34 £ per tablet

In brief

  • In our pharmacy, you can buy zaleplon without a prescription, with delivery in 9–21 days throughout the United Kingdom. Discreet and anonymous packaging.
  • Zaleplon 10 mg capsules (UK brand Sonata, now discontinued in the UK) are a non-benzodiazepine hypnotic for the short-term treatment of insomnia, especially difficulty falling asleep.
  • It enhances GABA-A receptor activity to promote sleep; it is a prescription-only medicine (POM) and a Class C controlled drug in the UK.
  • The usual adult dose is 10 mg immediately before bedtime; older or frail adults usually start at 5 mg, and treatment is kept short, normally 2-4 weeks.
  • It is taken by mouth as a capsule, swallowed whole just before getting into bed; a heavy meal can delay the effect.
  • It typically begins to work within about 15-30 minutes.
  • Its effect is short-lived, so it helps with falling asleep rather than staying asleep; do not take it unless at least four hours of sleep remain.
  • Do not drink alcohol while using it, as alcohol markedly increases sedation, breathing depression and impaired coordination.
  • Common side effects include drowsiness, dizziness, headache, memory problems and coordination problems; complex sleep-related behaviours are rare but serious.

Basic zaleplon information

  • INN (International Nonproprietary Name): Zaleplon
  • Brand names available in the United Kingdom: Sonata 10 mg capsules (discontinued in the UK)
  • ATC code: N05CF03
  • Forms & dosages: capsule, 10 mg, oral
  • Registration status in the United Kingdom: prescription only (POM); discontinued in the UK
  • OTC / Rx classification: Rx (POM); controlled drug (Class C)

Critical warnings, restrictions and patient protection (UK focus)

Zaleplon is a short-acting hypnotic prescribed only for short-term adult insomnia and is a prescription-only medicine.

Absolute contraindications include pregnancy, breastfeeding, severe hepatic impairment and prior complex sleep-related behaviours.

High-risk groups (elderly, pregnancy, chronic illness)

  • Pregnant Or Breastfeeding People (contraindicated).
  • Severe Hepatic Impairment (contraindicated).
  • History Of Substance Misuse Or Alcohol Dependence.
  • Significant Respiratory Disease, For Example Severe COPD Or Untreated Sleep Apnoea.
  • Elderly — Increased Sensitivity; Start Low; See Dosing Guidance.

If a patient develops mood change, worsening depression, suicidal ideation or complex sleep behaviours such as sleep-walking or sleep-driving they must contact their GP or pharmacist immediately.

Suspected serious adverse reactions and interaction concerns should be reported via the MHRA Yellow Card scheme.

Checklist for patient safety points

  • Confirm pregnancy and breastfeeding status before supply.
  • Check liver disease history and recent liver tests if indicated.
  • Assess alcohol and substance use history.

Interaction with activities (driving, workplace safety under UK law)

Do not drive, operate heavy machinery or engage in safety-critical work after taking zaleplon if feeling drowsy or less alert.

UK driving law requires fitness to drive and driving while impaired may be a criminal offence if alertness is reduced by medication.

Q&A — “Can I drive after taking it in the UK?”

Q: Can I drive after taking zaleplon?

A: No.

Do not drive or perform safety-critical tasks if you feel drowsy or less alert.

Even though zaleplon is short-acting, residual impairment and next-day effects are possible for some people.

Check with your GP or pharmacist before returning to driving, and stop the medicine and seek urgent advice if you experience complex sleep behaviours.

INN, brand names available in the UK

INN: Zaleplon is the international nonproprietary name for this short-acting hypnotic.

Z-drug: the term describes non-benzodiazepine hypnotics such as zaleplon that are used for insomnia.

Legal classification (POM, controlled status)

Clinicians and patients should verify local NHS formulary position and MHRA status when considering supply.

For patient handouts: POM means a prescription from a prescriber is required, P means pharmacy-only, and GSL indicates general sales list — zaleplon is POM.

Standard adult dosing (NHS-style)

The typical adult dose of zaleplon is 10 mg taken orally immediately before bedtime.

Take the capsule immediately before getting into bed and avoid taking it after a meal because a substantial meal delays onset.

Checklist before taking

  • Ensure there is at least four hours available for uninterrupted sleep before taking the dose.
  • Do not combine with alcohol or other central nervous system depressants on the same night.
  • Do not take another hypnotic or sedative during the same night.

Adjustments for comorbidities and special populations

Elderly patients have increased sensitivity and a 5 mg starting dose should be considered where appropriate and monitored.

Severe hepatic impairment is a contraindication.

Mild to moderate hepatic impairment requires dose reduction and clinical monitoring.

Q&A — “What if I miss a dose?”

Q: What should I do if I miss a dose?

A: Skip the missed dose.

Only take a dose later in the night if you have at least four hours remaining for sleep and you have not already taken a dose that night.

Prescriber documentation checklist

  • Record indication (sleep-onset insomnia) and starting dose in notes.
  • Note any hepatic impairment, substance misuse history or respiratory disease as red flags.

Food and drink interactions

Avoid alcohol while taking zaleplon because combined central nervous system depression increases the risk of excessive sedation and respiratory depression.

Avoid taking zaleplon immediately after a substantial meal as food may delay absorption and slow onset of effect.

Common drug conflicts and MHRA Yellow Card signals

High-risk co-medications include other CNS depressants such as opioids, sedating antidepressants, antipsychotics and sedating antihistamines due to additive sedation.

Medicines that reduce alertness, including some antihistamines and antipsychotics, increase risk when used with zaleplon.

Prescribers should monitor closely when co-prescribing agents that affect hepatic metabolism and consult the SPC and BNF for CYP interaction details.

Suspected interactions and adverse reactions should be reported using the MHRA Yellow Card scheme.

Patient counselling points

  • Do not mix zaleplon with alcohol or recreational drugs.
  • Seek advice if you are prescribed an opioid or strong CYP inhibitor such as certain antifungals or antibiotics.

Simplified explanation

Zaleplon is a short-acting sedative-hypnotic that enhances inhibitory GABAergic neurotransmission to help people fall asleep quickly.

Its short duration of action makes it primarily effective for reducing sleep-onset latency.

Clinical terms and classification

  • ATC code: N05CF03
  • Drug Class: Sedative-hypnotic, central nervous system depressant; commonly called a Z-drug.

Pharmacokinetic implications are rapid onset and short duration, so zaleplon is not suited for problems with sleep maintenance.

Drug Onset Duration Best Use
Zaleplon Rapid Short Sleep onset
Zolpidem Rapid to moderate Moderate Onset and some maintenance formulations

MHRA-approved indications

Zaleplon is approved for the short-term treatment of insomnia in adults, particularly when difficulty initiating sleep is the main complaint.

Recommended treatment duration is short-term, typically two to four weeks.

Off-label practices in NHS and private care

Off-label prescribing should be clearly justified, documented and include informed consent in the clinical record.

Examples of off-label use are limited and generally occur within clinician sleep clinics when alternatives are unsuitable.

Prescriber checklist for off-label or clinician use

  • Document the clinical indication and reasons why licensed alternatives were unsuitable.
  • Plan and document follow-up and monitoring for dependence and adverse effects.

Comparison table

Drug ATC Code Typical Dose Onset/Duration Pros/Cons
Zolpidem N05CF02 Typical 5–10 mg formulations Rapid/Moderate Available for onset and some maintenance formulations.
Short-Acting Benzodiazepines Various Variable Rapid/Variable Effective but higher risk of tolerance and dependence.

Pros and cons checklist for clinicians and patients

  • Match indication: onset versus maintenance problems.
  • Consider patient age and comorbidity including liver disease.
  • Assess history of substance misuse before prescribing.
  • Consider risk of next-day impairment for work or driving.

Common questions from United Kingdom patients

  • Q: Will I become addicted?
  • A: Dependence risk rises with longer use; short courses minimise the risk.
  • Q: Can I drink alcohol?
  • A: No — alcohol plus zaleplon increases sedation and respiratory risk.
  • Q: Is it safe if I have liver problems?
  • A: Severe hepatic impairment is contraindicated; mild to moderate requires dose adjustment and monitoring.

Use these FAQs on clinic leaflets and link to the MHRA and SPC for full prescribing and safety information.

MHRA approval and clinician supply

Prescribing and supply must meet MHRA and NHS rules and zaleplon is prescription-only and considered a controlled hypnotic.

Reporting safety concerns

Report suspected adverse drug reactions and interactions via the MHRA Yellow Card scheme.

For supply or availability issues contact your local NHS medicines optimiser or formulary team.

Checklist for pharmacists receiving an unusual prescription

  • Verify prescriber identity and prescription validity.
  • Confirm the patient’s suitability and screen for red-flag contraindications.

Home storage and child safety

Store zaleplon in the original blister or carton below 25°C in a dry place away from direct heat and humidity.

Keep out of reach of children and dispose of unused capsules via pharmacy medicine take-back schemes rather than flushing down the toilet.

Transport and controlled substance custody

No refrigeration is required for transport but controlled status requires secure custody during transit.

When travelling, carry medication in original packaging and bring prescription documentation if required for controlled drug checks.

Patient and pharmacist checklists

  • Patient: store in original packaging, keep away from children and return unused medicine to a pharmacy.
  • Pharmacist: handle returns and disposal per local policy and maintain required records for controlled supplies.

Pharmacist counselling checklist (recommended script items)

  • Confirm indication as sleep-onset insomnia and explain the short-term nature of treatment.
  • Explain dose: 10 mg immediately before bed, elderly may start at 5 mg; avoid after food.
  • Warn about alcohol and other sedatives and advise not to drive if drowsy.
  • Describe possible side effects and actions: stop and seek urgent care for complex behaviours or suicidal thoughts.

NHS patient safety advice and documentation

Document informed consent in the clinical record and provide a written patient information leaflet with the medicine supply.

Use shared decision making and clearly record reasons for choosing zaleplon versus alternatives.

Final notes and practical takeaways

Zaleplon (Sonata) is a prescription-only, short-acting Z-drug indicated for short-term treatment of sleep-onset insomnia in adults.

It is supplied as 10 mg oral capsules and has a rapid onset with a short duration, making it suitable primarily for falling asleep rather than staying asleep.

Report adverse events to the MHRA Yellow Card scheme and contact a pharmacist or GP if you have any concerns about side effects, driving or interactions.

In our online pharmacy, zaleplon is available without a prescription, with discreet delivery to United Kingdom in 9–21 days.

Delivery across the United Kingdom

City Region Delivery Time
London England 9–21 days
Birmingham England 9–21 days
Manchester England 9–21 days
Glasgow Scotland 9–21 days
Leeds England 9–21 days
Edinburgh Scotland 9–21 days
Bristol England 9–21 days
Belfast Northern Ireland 9–21 days
Cardiff Wales 9–21 days
Newcastle Upon Tyne England 9–21 days
Southampton England 9–21 days
Nottingham England 9–21 days
Sheffield England 9–21 days

Related products